http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2008119415-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-83 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
| filingDate | 2006-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2008119415-A |
| titleOfInvention | NEW VANILLOID RECEPTOR LIGAND COMPOUNDS AND USE OF SUCH COMPOUNDS FOR PREPARATION OF MEDICINES |
| abstract | 1. Substituted compounds of the general formula A! ! in which X denotes O, S or N-C≡N,! Y is —NH2, —NHR30, —NR31R32 or a linear or branched, saturated or unsaturated, unsubstituted or at least monosubstituted aliphatic C1-C10 residue! n is 0, 1, 2, 3 or 4,! R1, R2, R3 and R4 are independently H, F, Cl, Br, I, -SF5, -NO2, -CF3, -CN, -NH2, -OH, -SH, -C (= O) - NH2, -S (= O) 2-NH2, -C (= O) -NH-OH, -C (= O) -OH, -C (= O) -H, -S (= O) 2-OH , -NHR11, -NR12R13, -OR14, -SR15, -C (= O) -NHR16, -C (= O) -NR17R18, -S (= O) 2-NHR19, -S (= O) 2-NR20R21 , -C (= O) -OR22, -C (= O) -R23, -S (= O) -R24, -S (= O) 2-R24 or linear or branched, saturated or unsaturated, unsubstituted or at least least monosubstituted aliphatic C1-C10 residue,! R5 is H, F, Cl, Br, I, —SF5, —NO2, —CF3, —CF2Cl, —CN, —NH2, —OH, —SH, —C (= O) —NH2, —S (= O ) 2-NH2, -C (= O) -NH-OH, -C (= O) -OH, -C (= O) -H, -S (= O) 2-OH, -NHR11, -NR12R13, -OR14, -SR15, -C (= O) -NHR16, -C (= O) NR17R18, -S (= O) 2-NHR19, -S (= O) 2-NR20R21, -C (= O) - OR22, -C (= O) -R23, -S (= O) 2-R24, -S (= O) -R24, linear or branched, saturated or unsaturated, unsubstituted or at least monosubstituted aliphatic C1-C10 residue or unsaturated or saturated, unsubstituted or at least monosubstituted, optionally having a heteroatom as a ring member of a 3-, 4-, 5-, 6-, 7-, 8- or 9-membered cycloaliphatic residue, which through a carbon atom in its tse connected with the skeleton of the molecule! T stands for C-R6,! U stands for C-R7,! V denotes N and! W stands for C-R8, either! T stands for C-R6,! U is N,! V is C-R9 and! W stands for C-R8, either! T stands for N,! U stands for C-R7,! V denotes C-R9 and! W stands for C-R8, either! T stands for N,! U stands for N,! V denotes C-R9 and! W stands for C-R8, either! T stands for N,! U stands for C-R7,! V denotes N and! W stands for C-R8, either! T stands for C-R6,! U stands for N,! V denotes N and! W is C-R8, |
| priorityDate | 2005-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 173.